Caas Capital Management LP Abbott Laboratories Put Options Transaction History

Caas Capital Management LP

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 26, 2024	BUY	$109.52 - $120.96 $240,944 - $266,112	2,200 Added 220.0%	3,200 $363,000
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $1.98 Million - $2.42 Million	-21,900 Reduced 95.63%	1,000 $110,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $1.14 Million - $1.36 Million	-11,900 Reduced 34.2%	22,900 $2.22 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $644,992 - $718,656	-6,400 Reduced 15.53%	34,800 $3.79 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $2.47 Million - $2.91 Million	25,500 Added 162.42%	41,200 $4.17 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.49 Million - $1.75 Million	15,700 New	15,700 $1.72 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $3.71 Million - $4.52 Million	-32,500 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $21 Million - $24.7 Million	-192,500 Reduced 85.56%	32,500 $3.9 Million
Q3 2020 Nov 09, 2020	BUY	$91.64 - $111.29 $2.29 Million - $2.78 Million	25,000 Added 12.5%	225,000 $24.5 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $15.3 Million - $19.6 Million	200,000 New	200,000 $18.3 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.